Associate Professor Amy McCart Reed holds a PhD in molecular biology from the University of Queensland and has undertaken a series of studies investigating the genomic landscape of breast cancer special types.

She is passionate about breast cancer clinical research, biobanking, and precision oncology. In addition to her breast cancer research portfolio, she is on the Scientific Advisory Board for Breast Cancer Trials. We spoke with her about lobular prognostic biomarkers and their role in breast cancer diagnoses.